Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA

BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive B-non-Hodgkin lymphoma with generally poor outcome. MCL is characterized by an aberrantly high cyclin D1-driven CDK4 activity. New molecular targeted therapies such as inhibitors of the ubiquitin-proteasome system (UPS) have shown promising res...

Descripción completa

Detalles Bibliográficos
Autores principales: Heine, Simon, Kleih, Markus, Giménez, Neus, Böpple, Kathrin, Ott, German, Colomer, Dolors, Aulitzky, Walter E., van der Kuip, Heiko, Silkenstedt, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123978/
https://www.ncbi.nlm.nih.gov/pubmed/30180865
http://dx.doi.org/10.1186/s13045-018-0657-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123978/
https://www.ncbi.nlm.nih.gov/pubmed/30180865
http://dx.doi.org/10.1186/s13045-018-0657-6

Ejemplares similares